Literature DB >> 3527688

Genetics of adrenal steroid 21-hydroxylase deficiency.

M I New, P W Speiser.   

Abstract

Impairment of 21-hydroxylation is the most common enzymatic deficiency resulting in the syndrome of CAH, which may present either in the classical form in infants or in the nonclassical form in older individuals. Variable signs and symptoms of androgen excess are common to both types of the disorder, which are transmitted as autosomal recessive traits linked to HLA. Virilization begins in the second month of gestational life in classical 21-OHD, but postnatally in the nonclassical form. Salt wasting is a feature of the disease in a large number of classical patients; in the simple virilizing form aldosterone biosynthesis, a function of the adrenal zona glomerulosa, is intact. Additionally, no patient with nonclassical 21-OHD has been found to have salt wasting. Levels of precursor hormones are less markedly elevated in nonclassical 21-OHD, reflecting a less severe enzyme deficiency; coordinates of basal and stimulated 17-OHP are plotted on a nomogram to ascertain diagnostic category within a family. Confirmatory evidence of heterozygosity within the family of an affected proband is found by performing HLA typing. Specific linkage disequilibria exist for the classical and nonclassical forms of 21-OHD. Frequency of the classical disease is 1/5,000-1/15,000 in Caucasians, whereas the nonclassical disease is found in approximately 1/100 individuals in the Caucasian population, placing the latter disorder among the most common autosomal recessive disorders in man. A deletion of the active 21-hydroxylase gene has been detected in some classical patients; further investigations are in progress to elucidate the molecular genetics of this disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527688     DOI: 10.1210/edrv-7-3-331

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  7 in total

1.  HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.

Authors:  F Parlato; G Pisano; G Misiano; E Cosentini; C Cacciapuoti; M R Cavalcanti; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

Review 2.  Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a 10 year experience.

Authors:  M G Forest; M David
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

Review 3.  21-Hydroxylase deficiency: from molecular genetics to clinical presentation.

Authors:  E Trakakis; D Laggas; E Salamalekis; G Creatsas
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

4.  Major-histocompatibility-complex gene markers and restriction-fragment analysis of steroid 21-hydroxylase (CYP21) and complement C4 genes in classical congenital adrenal hyperplasia patients in a single population.

Authors:  J Partanen; S Koskimies; I Sipilä; V Lipsanen
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

5.  Prenatal diagnosis of congenital adrenal hyperplasia: reliability of amniotic fluid steroid analysis.

Authors:  I A Hughes; J Dyas; D Riad-Fahmy; K M Laurence
Journal:  J Med Genet       Date:  1987-06       Impact factor: 6.318

6.  Prevalence of late-onset adrenal hyperplasia in postmenarchal hirsutism.

Authors:  P Motta; A Catania; L Airaghi; I Mangone; L Cantalamessa; C Zanussi
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

7.  170H-progesterone rhythms in congenital adrenal hyperplasia.

Authors:  M C Young; J A Robinson; G F Read; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.